Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × pasireotide × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 CNS 1

Conditions

Peritoneal Neoplasms 1

Interventions

Paclitaxel 57 Carboplatin 54 Cisplatin 28 pembrolizumab 25 liposomal doxorubicin 20 Cyclophosphamide 20 Topotecan 17 Gemcitabine 16 Bevacizumab 16 Docetaxel 12 niraparib 11 fludarabine 10 Taxes 9 Nivolumab 9 aldesleukin 7 Surveys and Questionnaires 7 Doxorubicin 7 olaparib 6 fludarabine phosphate 6 avelumab 6 Oxaliplatin 6 Interleukin-2 6 Cytoreduction Surgical Procedures 6 rucaparib 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Hyperthermic Intraperitoneal Chemotherapy 5 Fluorodeoxyglucose F18 5 Filgrastim 5 Brachytherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡